Sign in Subscribe
Genes

Genetic Associations with Steatosis in Obesity and Diabetes

Strategic Insights

— 1 min read

Researchers at Minia University have made significant findings in the realm of obesity and diabetes, focusing on the genetic factors underlying metabolic dysfunction-associated steatotic liver disease (MASLD). The study, published in the Egyptian Liver Journal, investigated the role of cholesteryl ester transfer protein (CETP) gene variants in MASLD susceptibility. The researchers aimed to uncover genetic links to steatosis development, with a total of 100 participants categorized into four groups based on their demographic and clinical characteristics.

Key Takeaways:

  • The study found that CETP gene variants influence MASLD severity, with significant differences in lipid profiles and metabolic characteristics among the four study groups.
  • The wild-type CC genotype was linked to higher hepatosteatosis index (HSI) and fatty liver index (FLI) scores, indicating more severe steatosis in obese diabetics.
  • The mutant AA genotype was associated with lower HSI and FLI scores, suggesting protection against steatosis in lean non-diabetic individuals.
  • The study highlights the importance of genetic predispositions in the development of MASLD, in addition to metabolic and lifestyle factors.
  • The researchers recruited 100 participants from Minia University's outpatient clinic between 2021 and 2022, with 70% of the participants being female and 28% having hypertension.
  • The study's findings have implications for the understanding and management of MASLD, with potential therapeutic interventions targeting CETP gene variants.

Statistics:

  • 100 participants were recruited for the study, with 80 MASLD patients and 20 controls.
  • 70% of the participants were female, while 28% had hypertension.
  • Lipid profiles showed significant differences in total cholesterol and triglycerides among the four study groups (P < 0.05).
  • The wild-type CC genotype was associated with higher HSI (6.2 ± 1.1) and FLI (32.9 ± 4.5) scores, while the mutant AA genotype was associated with lower HSI (4.5 ± 1.5) and FLI (22.1 ± 3.9) scores.

Sources:

  • NewsRx. Studies from Minia University Have Provided New Data on Obesity and Diabetes (Cholesteryl ester transfer protein gene variants and metabolic dysfunction-associated steatotic liver disease: genetic associations with steatosis in obese and lean ...). Obesity & Diabetes Week. November 3, 2025; p 163.
  • Egyptian Liver Journal. Cholesteryl ester transfer protein gene variants and metabolic dysfunction-associated steatotic liver disease: genetic associations with steatosis in obese and lean individuals. 2025, 15(1):1-13.

Read more